UK markets close in 4 hours 6 minutes

Ionis Pharmaceuticals, Inc. (0JDI.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
41.77-0.48 (-1.14%)
As of 07:00PM BST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.40
52-week change 319.66%
S&P500 52-week change 321.83%
52-week high 353.94
52-week low 30.00
50-day moving average 348.72
200-day moving average 344.34

Share statistics

Avg vol (3-month) 3351
Avg vol (10-day) 3342
Shares outstanding 5137.57M
Implied shares outstanding 6N/A
Float 8144.53M
% held by insiders 10.86%
% held by institutions 1100.99%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -46.50%
Operating margin (ttm)4.79%

Management effectiveness

Return on assets (ttm)-7.51%
Return on equity (ttm)-76.34%

Income statement

Revenue (ttm)787.65M
Revenue per share (ttm)5.50
Quarterly revenue growth (yoy)113.60%
Gross profit (ttm)N/A
EBITDA -319.22M
Net income avi to common (ttm)-366.29M
Diluted EPS (ttm)-0.03
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.34B
Total cash per share (mrq)16.04
Total debt (mrq)1.97B
Total debt/equity (mrq)508.75%
Current ratio (mrq)5.90
Book value per share (mrq)2.68

Cash flow statement

Operating cash flow (ttm)-307.51M
Levered free cash flow (ttm)-159.99M